N/A
N=335
Heart Failure Study: The Atlanta Cardiomyopathy Consortium
Heart Failure
Bottom Line
View on ClinicalTrials.gov: NCT00599014 ↗Enrolled (actual)
335
Serious AEs
—
Results posted
Jan 2014
Primary outcome: Primary: Death, Heart Transplant, Left Ventricular Assist Device Implantation — 35 participants
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- —
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Emory University
- Primary completion
- Jun 2013
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Death, Heart Transplant, Left Ventricular Assist Device Implantation |
35 | — |
| SECONDARY Hospitalization |
84 | — |
Summary
Heart failure is a very common cause of hospital admission and there are half a million new cases diagnosed each year in the United States. While some important progress has been made over the last two decades for the treatment of heart failure, there still remains a critical need for further advances in our understanding of this disease in order to significantly improve patient outcomes. Large numbers of heart failure patients need to be studied over time to allow scientists to investigate those factors that influence the responses to therapy.
Eligibility Criteria
Inclusion Criteria
- Age: 18 years and over
- Sex: Both
- Ethnic Origin: All
- Diagnosis required to participate: Clinical diagnosis of systolic or diastolic heart failure
Exclusion Criteria
- Congenital heart disease
- Previous heart transplantation
- No primary infiltrative disease i.e. amyloidosis
Data sourced from ClinicalTrials.gov (NCT00599014). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.